Knowing the risks and minimizing them

---

Potential Hazards

In the laboratory, there are a large variety of potential risks. We will detail them and how they are managed by the LISBP in the next section.

Main hazards:

External risks (earthquake, security issues, etc

The LISBP is concerned by many different types of hazards due to a wide spectrum of scientific activities. One hazard category includes risks that are not directly linked to the LISBP research activity such as those due to working conditions (noise, thermal atmosphere, etc.), electrical hazards, work on computer screens, falls, and so on. The main hazard categories concern the substances handled for research purposes such as class 1 microorganisms (GMO or not), urban wastewaters, chemical products among including CMRs, cryogenic fluids, to name a few. A second main hazard category relates to equipment and pilot plants with specific risks such as equipment using pressurized liquids, gases or steam (autoclaves), instruments generating non-ionizing radiations (Laser, UV lights) and electromagnetic radiation (RMN).

Hazardous chemicals:

List of hazardous, chemicals & inventory:

The list of hazardous, chemicals and inventory is managed independently by each LISBP sub group. A common LISBP list of CMR substances is monitored and updated.

Waste management plan:

The chemical waste is managed in accordance with the environmental code. First, the waste is stored on a specially adapted LISBP/INSA site, before being disposed of by a subcontracted service provider in accordance with the ADR rules concerning the waste treatment, valorization or destruction. Each waste removal is accompanied by tracking forms for monitoring of hazardous waste.

Vacuum/pressurized equipment:

Pressurized equipment is monitored according to from 15 March 2000 Decree concerning work with vacuum and high-pressure equipment.

Cryogenic/high temperature equipment:

Implementation of adequate means of prevention.

Biological safety:

Biological safety plan:

The laboratory applies the measures stated in the articles of French Labour Code: L.4421-1 and R. 4421-1 a R. 4427-5 (Directive 90/619 on life insurance from 26 November 1990).

Biological material Type of organism used:

The E. coli and P. pastoris strains that we use are non-pathogenic and their genomes are very well characterized. These organisms are classified in the Risk group 1, which is the lowest level. These organisms do not cause diseases in healthy adult humans. (However, they might cause diseases in young children, elderly people, or people with immune system deficiencies.). All media and materials were autoclaved to ensure we will not disseminate GMOs outside the lab.

Biosafety cabinets:

The use of PSM type II guarantee the sterility of the manipulation and the protection of the environment and of the manipulator.

Decontamination plan:

Certain laboratory rooms are subjected to gaseous decontamination once per year or upon request.

Biological waste management plan:

Biological waste (liquid or solid) is pretreated chemically (bleach) or by autoclaving. Glass, sharp or jagged objects are disposed via a specialized company (DASRI).

Biological emergency plan (exposure spill):

In case of exposure spill, liquids are absorbed through suitable means and further treated as biological waste.

Good laboratory practices

Thanks to the experience of our supervisors and the safety department, we received training about the safety in the lab that taught us some basic rules. We therefore inherited the accumulated experience of all these experts in their respective fields.

Safety and project construction

---

Safety management, French legislation and ethics played an important role in the way we managed our project. The brainstorming process was particularly affected by these points. We wanted to work on a project that can live outside the iGEM competition and outside the lab. So, quite early on, we selected our ideas depending on “will the use of GMOs become an issue for customer safety and also that of the environment”. Our Cerberus project needs GMOs but we have developed it to avoid any contact for the product user but also with the environment. The final goal of the project is to produce a protein in the laboratory through GMOs but only the protein, and not the organism that produced it, is used.

If this part of our project construction interests you, we invite you to read the Human Practices section.